Presentation Controversies and Advances 2017 Does IMPROVE-IT and FOURIER. Confirm or Refute the LDL Hypothesis? Presenter: Sanjay Kaul November 16, 2017
Presentation Controversies and Advances 2017 Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It? Presenter: Sanjay Kaul November 16, 2017
Presentation Controversies and Advances 2017 Sex Considerations in the FDA Drug Review Pipeline and Drug Trial Snapshots Presenter: Marjorie R. Jenkins November 16, 2017
Presentation Controversies and Advances 2017 Rise, Fall And Resurrection of Renal Denervation Presenter: Michael A. Weber November 16, 2017
CME Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice
CME Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice
News Industry News Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat